-
Occupational Disease Claims and Payments in Indonesia: Insights From Administrative Data 2018-2022
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Longitudinal Trends in Biosimilar Uptake in France 2019-2024: Insights by Dispensing Pathway and Prescribing Origin
Sep 9, 2025, 16:22 PM -
Delta Price Cost-Effectiveness Analysis of PCV21 vs. PCV20 Use in Adults Aged ≥18 Years in Austria
Sep 9, 2025, 16:22 PM -
Population Reference Costs for Average Total Annual Care in the UK National Health Service for 11 Common Diseases or Conditions vs. Matched Controls
Sep 9, 2025, 16:22 PM -
Optimizing Healthcare Systems in the MENA Region: Insights From Tailored Reimbursement for Innovative and Generic Essential Remedies (TRIGER) Meetings in Saudi Arabia and Algeria
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Bispecific Antibodies in Europe: A Systematic Review
Sep 9, 2025, 16:22 PM -
Use of the ESMO-Magnitude of Clinical Benefit Scale to Guide HTA Recommendations on Coverage and Reimbursement for Cancer Medicines in Ireland: A Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Piloting a GenAI Agent for Structured Quality Appraisal of Network Meta-Analyses Using the ISPOR-AMCP-NPC Checklist
Sep 9, 2025, 16:22 PM -
Assessing the Cost-Effectiveness of Semaglutide 2.4 mg in the Management of People With Obesity and Knee Osteoarthritis in the UK
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Individual Service and Training Interventions for Self-Harm and Suicide Prevention: A Systematic Review
Sep 9, 2025, 16:22 PM -
A Prevalence-Weighted ICER Approach With Scenario Analyses for HTA Without RCT Evidence
Sep 9, 2025, 16:22 PM -
Adapting HTA Frameworks for Precision Medicine: Methodological Advances in the UK and EU4
Sep 9, 2025, 16:22 PM -
Social Determinants of Health Affecting Response to Opioid Addiction Treatment
Sep 9, 2025, 16:22 PM -
Economic Valuation of Premature COVID-19 Mortality in Kuwait: A Comparative Analysis of Three Methodological Approaches
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine From Lower-Valent Vaccines in the French Pediatric Population
Sep 9, 2025, 16:22 PM -
Exploring Methodologies for Defining and Modeling Cure in Melanoma: Impacts on Estimating Cure Metrics
Sep 9, 2025, 16:22 PM -
Harmonization or Hindrance? A Strategic Analysis of Divergent National Requirements Under the EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Targeted Review of mITT vs. ITT Data in CAR-T Submissions
Sep 9, 2025, 16:22 PM -
Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?
Sep 9, 2025, 16:22 PM
